INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Cambridgeshire and Peterborough NHS Foundation Trust
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de Cambridgeshire and Peterborough NHS Foundation Trust (63)
2024
-
Clinical presentation of psychotic experiences in patients with common mental disorders attending the UK primary care improving access to psychological therapies (IAPT) Programme
Journal of Affective Disorders, Vol. 344, pp. 233-241
-
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272
2023
-
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants
Schizophrenia bulletin, Vol. 49, Núm. 3, pp. 614-625
-
Economic evaluation of interventions for treatment-resistant depression: A systematic review
Frontiers in Psychiatry, Vol. 14
-
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk
Schizophrenia Bulletin Open, Vol. 4, Núm. 1
-
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol
Psychological Medicine
-
Orthorexia nervosa in gay men—the result of a spanish-polish eating disorders study
BMC Public Health, Vol. 23, Núm. 1
-
Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scale
Schizophrenia, Vol. 9, Núm. 1
-
Stratification of adolescents across mental phenomena emphasizes the importance of transdiagnostic distress: a replication in two general population cohorts
European Child and Adolescent Psychiatry, Vol. 32, Núm. 5, pp. 797-807
-
Umbrella review of nursing interventions NIC for the treatment and prevention of suicidal behavior
International Journal of Nursing Knowledge, Vol. 34, Núm. 3, pp. 204-215
2022
-
A clozapine's uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agency
Revista de Psiquiatria y Salud Mental
-
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report
European Archives of Psychiatry and Clinical Neuroscience, Vol. 272, Núm. 3, pp. 461-475
-
Determinants of patient-reported outcome trajectories and symptomatic recovery in Improving Access to Psychological Therapies (IAPT) services
Psychological Medicine, Vol. 52, Núm. 14, pp. 3231-3240
-
The Peterborough Exemplar: a protocol to evaluate the impact and implementation of a new patient-centred, system-wide community mental healthcare model in England
Health Research Policy and Systems, Vol. 20, Núm. 1
-
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis
Schizophrenia Bulletin Open, Vol. 3, Núm. 1
-
The impact of the initial COVID-19 outbreak on young adults’ mental health: a longitudinal study of risk and resilience factors
Scientific Reports, Vol. 12, Núm. 1
-
Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapists
BMJ open, Vol. 12, Núm. 6, pp. e056355
-
What outcomes matter to service users who experience persistent depression: A mixed-method narrative review and synthesis
Journal of Affective Disorders Reports, Vol. 10
2021
-
Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
Translational Psychiatry, Vol. 11, Núm. 1
-
Breaking the web: Life beyond the at-risk mental state for psychosis
Psychological Medicine, Vol. 51, Núm. 6, pp. 934-939